What is PowerVision?
Headquartered in Belmont, California, PowerVision operates at the intersection of medical innovation and advanced engineering. The company specializes in the development of sophisticated medical devices and equipment, positioning itself as a critical player in the healthcare technology ecosystem. With a lean, high-performance team of 10 to 19 professionals, the firm has demonstrated remarkable efficiency, generating annual revenues between $5M and $10M. Its market position is bolstered by a focus on high-growth therapeutic areas, where it leverages deep technical expertise to address unmet clinical needs and improve patient outcomes through precision-engineered solutions.
How much funding has PowerVision raised?
PowerVision has raised a total of $93.5M across 4 funding rounds:
Series A
$4.4M
Series B
$20M
Series C
$24M
Series D
$45.1M
Series A (2005): $4.4M with participation from Frazier Healthcare Partners and JPMorgan Partners (JPMP)
Series B (2007): $20M led by Advanced Technology Ventures, JPMorgan Chase, and Frazier Healthcare Ventures
Series C (2011): $24M supported by Advanced Technology Ventures, Panorama Capital, Medtronic, Inc., Venrock, and Frazier Healthcare Ventures
Series D (2014): $45.1M featuring Advanced Technology Ventures, BA Venture Partners, Medtronic, Inc., Venrock, Correlation Venture Partners, Aisling Capital, Lexington Partners, Frazier Healthcare Ventures, and Johnson & Johnson Development Corporation
Key Investors in PowerVision
Advanced Technology Ventures
A bi-coastal venture capital firm with $1.4 billion under management, specializing in building emerging-growth business ventures into market leaders across healthcare and IT sectors.
Medtronic, Inc.
A global healthcare technology leader that develops and manufactures medical devices, therapies, and digital health solutions to improve patient outcomes worldwide.
Venrock
A historic venture capital firm headquartered in Palo Alto, known for its deep industry expertise and commitment to helping high-growth healthcare and technology startups scale.
What's next for PowerVision?
With the infusion of capital from its most recent strategic investment, PowerVision is well-positioned to accelerate its research and development pipeline. The company is expected to focus on the commercialization of its next-generation medical technologies, potentially expanding its reach into new international markets. Given the historical support from industry giants like Medtronic and Johnson & Johnson, the firm is likely to prioritize strategic partnerships that enhance its distribution capabilities and clinical validation efforts. As it moves beyond the scaling phase, PowerVision remains a prime candidate for further market disruption, leveraging its robust intellectual property portfolio to maintain a competitive edge in the evolving healthcare landscape.
See full PowerVision company page
